BridgeBio Pharma (BBIO) Total Debt Growth (1y) (2019 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 5.94% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | 103.99% |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 0.07% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | - |
| 10 | BridgeBio Pharma | 12.91 Bn | 11.98 Bn | 184.58 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3.56% |
| Sep 30, 2025 | 69.73% |
| Dec 31, 2024 | 22.11% |
| Sep 30, 2024 | -1.25% |
| Jun 30, 2024 | -1.15% |
| Mar 31, 2024 | -0.24% |
| Dec 31, 2023 | 3.59% |
| Sep 30, 2023 | 4.43% |
| Jun 30, 2023 | 5.29% |
| Mar 31, 2023 | 0.38% |
| Dec 31, 2022 | 0.06% |
| Sep 30, 2022 | 310.10% |
| Jun 30, 2022 | 307.71% |
| Mar 31, 2022 | 359.83% |
| Dec 31, 2021 | 358.84% |
| Sep 30, 2021 | 10.44% |
| Jun 30, 2021 | 10.44% |
| Mar 31, 2021 | 2.16% |
| Dec 31, 2020 | 2.27% |
| Sep 30, 2020 | 24.49% |
| Jun 30, 2020 | 23.88% |
| Dec 31, 2019 | 68.40% |